AB2 Bio

    OverviewSuggest Edit

    AB2 Bio operates as a drug discovery and development company that specializes in developing therapies for the treatment of severe systemic inflammatory diseases. The Company primarily focuses on developing drugs that treat the symptoms, as well as target the underlying causes of inflammation-based diseases. Its portfolio includes Interleukin-18 Binding Protein, a human protein with a high affinity for IL-18, a major inflammatory cytokine for inflammatory diseases treatment.

    HQLausanne, CH


    AB2 Bio is headquartered in
    Lausanne, Switzerland

    Location Map

    Latest Updates

    Employees (est.) (Oct 2019)23(-4%)

    Key People/Management at AB2 Bio

    Andrew Sleight

    Andrew Sleight

    Fernando Cunha

    Fernando Cunha

    Eduardo Schiffrin

    Eduardo Schiffrin

    Medical Director
    Show more

    AB2 Bio Office Locations

    AB2 Bio has an office in Lausanne
    Lausanne, CH (HQ)
    EPFL Innovation Park Building B
    Show all (1)

    AB2 Bio Financials and Metrics

    Summary Metrics

    Founding Date


    AB2 Bio latest funding size

    CHF20.87 m

    Time since last funding

    4 years ago
    Show all financial metrics

    AB2 Bio Online and Social Media Presence

    Embed Graph

    AB2 Bio Frequently Asked Questions

    • When was AB2 Bio founded?

      AB2 Bio was founded in 2010.

    • Who are AB2 Bio key executives?

      AB2 Bio's key executives are Andrew Sleight, Fernando Cunha and Eduardo Schiffrin.

    • How many employees does AB2 Bio have?

      AB2 Bio has 23 employees.

    • Who are AB2 Bio competitors?

      Competitors of AB2 Bio include Pandion Therapeutics, MedDay and NeuralStem.

    • Where is AB2 Bio headquarters?

      AB2 Bio headquarters is located at EPFL Innovation Park Building B, Lausanne.

    • Where are AB2 Bio offices?

      AB2 Bio has an office in Lausanne.

    • How many offices does AB2 Bio have?

      AB2 Bio has 1 office.